BUSINESS
After 20 years of losses, gene therapy specialist Oxford BioMedica is at last close to achieving its first profit thanks to the success of Novartis with a pioneering cancer treatment.
After 20 years of losses, gene therapy specialist Oxford BioMedica is at last close to achieving its first profit thanks to the success of Novartis with a pioneering cancer treatment.
As manufacturer of the virus-based gene delivery system central to the Novartis therapy, which re-engineers a patient's immune cells to attack cancer, the small British company will receive a modest slice of the revenue once the new drug is approved.
The payout will hardly make a dent in returns for Swiss drugs giant Novartis, but the 65-75 million pounds ($83-96 million) a year that Jefferies analysts predict Oxford Bio will earn should put it on a path to sustainable profitability.
U.S. regulators are expected to clear Novartis's CTL019, or tisagenlecleucel, for sale by the end of September, which would be the first approval of such a gene-modified drug.
For Oxford Bio, which listed in London in 1996 after being spun out of research at the University of Oxford, it has been a long haul marked by drug setbacks and funding challenges.
"It's a survival story. There have been bad times but we can see a very bright future," Chief Executive John Dawson told Reuters. "We're in a good place now."
The company's slow road to profit mirrors the waxing and waning of the gene therapy field over two decades as progress in fixing faulty DNA has been held up by technical problems and safety concerns. Now, finally, those hurdles are being cleared and Oxford Bio is set to be a supply chain winner.
The company is already earning revenue from manufacturing for Novartis and its earnings before interest, depreciation and amortisation were actually positive in the first half of 2017, though interest charges still pushed the group to a loss.
Consensus analyst forecasts point to full-year net profit from 2019, by which time CTL019 is likely to be established for the bigger market of treating certain lymphomas, in addition to initial use in acute lymphoblastic leukaemia.
MORE DEALS
Oxford Bio, which will receive royalties on sales as well as manufacturing fees, is now looking to leverage its successful partnership with Novartis to sign more supply deals.
"The phones are very busy from other companies who would like to work with us," Dawson said. "I believe we will sign further deals in 2017 and 2018."
One lure for partners is the progress Oxford Bio has made recently in production costs, achieving a tenfold reduction by using new bioreactors.
After a long period in the doldrums, shares in the group are up 112 percent this year, buoyed by rising optimism for CTL019, which represents the first in a new class of medicines known as CAR-T, or chimeric antigen receptor T-cell therapy.
But with a market value of a little less than $350 million, Oxford Bio remains a relative minnow compared with Bluebird Bio, a U.S. rival that uses the same lentiviral gene delivery technology and is worth $4.4 billion.
That partly reflects lower valuations for biotechnology in Europe, Dawson says, but it is also a function of the fact that the big money in gene therapy will be made by companies that own the drugs rather than those that simply help to make them.
Last September Dawson made the difficult decision to shore up Oxford Bio's finances by pausing much of the development work on its proprietary gene therapy pipeline while it seeks funding partners.
But he is optimistic that these projects -- including a Parkinson's disease drug ready to start clinical trials next year -- will move forward with backing from big pharma or venture capital groups excited by the gene therapy renaissance.
"There's upside in our share price to come."
($1 = 0.7811 pounds)
(This article has not been edited by DNA's editorial team and is auto-generated from an agency feed.)
Darshan case: Karnataka HC reserves order on jailed actor's bail plea
DNA TV Show: Congress’ fresh allegations against SEBI chief Madhabi Puri Buch
Mukesh Ambani acquires another company after 3 years, it manufactures...
Hyderabad: Visually challenged couple lives unaware with son's body for 4 days
Noel Tata makes first major appearance since Ratan Tata's demise, seen at...
J-K: Light snowfall in higher reaches of Kashmir, IMD predicts cloudy weather for...
WATCH: Son gets Rs 3 lakh porn movie offer, his mom's reaction goes viral
Bigg Boss 18: Vivian Dsena's wife Nouran Aly gives stern warning to Karan Veer Mehra, says don't...
Bollywood’s biggest flop sold only 500 tickets, made at Rs 45 cr, it earned only…, it starred…
7th Pay Commission: Diwali GIFT for govt employees of this state, DA hiked by...
Instagram down: Users face issues while sending messages, say, 'Rehne do fir'
Bigg Boss 18: Nyrraa Banerji opens up on her 'love angle' with Shehzada Dhami, says 'both of us...'
Ahead of Diwali, Akshay Kumar donates Rs 10000000 in Ayodhya for...
Dhanteras 2024 Shubh Muhurat: Puja timings, vidhi and what to buy
Mukesh Ambani's company gets RBI approval, set to operate as an online...
Who is the richest kid of Mukesh Ambani and Nita Ambani? Is it Akash, Isha or Anant? Know here
Watch: Amazon Alexa launches Diwali rocket, viral video stuns internet
Dimple Kapadia reacts to being social media savvy like Zeenat Aman: 'If I’ll ever be....'
Amid affair rumours with Abhishek Bachchan, Nimrat Kaur requests everyone to...
Rising Trends In Fertility Due To Environmental Pollution
Andrew Spira's New Book: A Guide To Entrepreneurial Resilience
What Makes Furniture Truly Cosy?
Delhi NCR news: Delhi Police, NCB bust meth lab in Noida, 5 arrested
Good news for Gautam Adani on Dhanteras 2024, his flagship company's profit jumps to Rs...
IND vs NZ: Star bowler called up to India’s squad for 3rd Test, likely to make debut in Mumbai
Meet woman, who cracked UPSC exam on her first attempt at age 23, to become...
Amid Aishwarya Rai-Abhishek Bachchan divorce rumours, know what 'grey divorce' means
IND vs NZ: India’s another landmark record at stake in Mumbai Test vs New Zealand
Who is Sheikh Naim Qassem, the new chief of Lebanon's Hezbollah?
PM Modi launches health cover for senior citizens; know eligibility, how to apply here
Chhoti Diwali 2024: Know significance of celebration, shubh muhurat, rituals and more
College student jumps from 4th floor of hostel thinking he had...
'Not Saint, Sadhu or...': Jaya Kishori hits back at trolls slamming her for Dior bag
Aishwarya Rai’s remark on divorce plans with Abhishek Bachchan goes viral: ‘We don’t even…’
Sunita Williams sends Diwali wishes from space, here's what she said; watch
Diwali 2024 long weekend: Banks to remain closed for four days in THESE states, full list here
'Monopoly Bachao Syndicate': LoP Rahul Gandhi alleges 'nexus' among Adani Group, BJP and...
Good news for Indians, Russia to offer visa-free travel by...
Big trouble for Gautam Adani, SEBI slaps show-cause notice to Adani Power, shares price fall by...
Two killed, several injured in Metro construction site accident in Patna, probe underway
Mukesh Ambani's BIG Diwali gift, JioFinance app will now let you buy gold for just Rs...
Mukesh Ambani's JioSaavn's festive offer: 3-month subscription for just Rs...
Baba Siddique's son Zeeshan Siddique gets threat message; accused held from Noida
J-K attack: Army dog 'Phantom' dies in anti-terror operation, honoured for sacrifice
Glenn Maxwell reveals Virat Kohli blocked him on Instagram after...
Mukesh Ambani's Diwali gift to Reliance employees is a box of..., watch viral video
Fashion designer Ratul Sood passes away playing golf in Kolkata
UP govt announces big gift ahead of Diwali, all employees of THIS department to be made permanent
How can AI, ML skills help sharpen problem-solving abilities in children?
Kerala: Over 150 injured, 8 critical, in fireworks accident during temple festival
Ratan Tata's Rs 10,000 crore Will: Who gets what? Here's all the details
Delhi-NCR AQI today: Delhi air quality remains 'very poor' ahead of Diwali despite firecracker ban
Ex-Pakistani cricketer takes brutal dig at Rohit Sharma, calls India 'Kagaz se sher aur...'
Is stock market open or closed on Dhanteras? Know details here
Kunal Kamra accepts Bhavish Aggarwal's 'join Ola' offer, has THESE demands
Education ALERT: Avoid these courses at all costs, no job guarantees
Salman Khan can’t take his eyes off Aishwarya Rai in viral video, fans say ‘inki shaadi hoti toh…’
Ahead of Diwali and Chhath Puja, Railways to run 250 special trains from today: Check full list
Israel passes law banning UNRWA operations in country: What does that mean?
Happy Dhanteras 2024: Wishes, WhatsApp messages, quotes, greetings to share with your loved ones
Delhi traffic advisory issued for ‘Run For Unity’ today, check list of routes to avoid here
Amazon Great Indian Festival Sale 2024 ends today, don't miss these fantastic deals